Adenocaine is a cardioprotective cardioplegia from Hibernation Therapeutics

Board of Directors

Board of Directors

Mitch Cybulski
Past Chairman International, SmithKline Beecham Plc, with 30+ years experience in the pharmaceutical industry
David C. Field
20+ years of management, sales, marketing and R&D experience in the medical industry
Christopher T. Collins
Investment Manager, past Senior Vice President for Morgan Stanley and Merrill Lynch, Pierce, Fenner & Smith
Stephan A. Fitch
25 year investment banking & private equity experience, Co-founder and Managing Director of IAG Holdings Ltd.
Peter J. Duffy
Partner of Wilson/Ryan/Grose, specializing in commercial, business, property, securities, and taxation law
Hugh F. Smisson III, MD
Practicing Neurosurgeon and Entrepreneur, specializing in venture start-ups in the biomedical industry
Geoffrey P. Dobson MSc, PhD
Professor of Physiology and Pharmacology, 25+ years experience in scientific discovery, cell injury and cardioprotection
Jim Burnell D.Phil., B.Sc.
Professor of Biochemistry and Molecular Biology, James Cook University, Queensland, Australia